Survival Analysis Rick Chappell, Ph.D. Professor,

Slides:



Advertisements
Similar presentations
The analysis of survival data in nephrology. Basic concepts and methods of Cox regression Paul C. van Dijk 1-2, Kitty J. Jager 1, Aeilko H. Zwinderman.
Advertisements

Surviving Survival Analysis
Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.
Departments of Medicine and Biostatistics
6/1/2015survival analysis 1 If you want peace, you must first have peace of mind. To have peace of mind, you must first act according to reason. With reason,
Intermediate methods in observational epidemiology 2008 Instructor: Moyses Szklo Measures of Disease Frequency.
Main Points to be Covered
Lecture 3 Survival analysis. Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: –ANOVA on mean survival.
Biostatistics in Research Practice Time to event data Martin Bland Professor of Health Statistics University of York
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
EVIDENCE BASED MEDICINE
Analysis of Complex Survey Data
1Statistics 741, Chappell - Spring 2012 Rick Chappell, Ph.D. Professor, Department of Biostatistics and Medical Informatics Department of Statistics University.
Survival Analysis: From Square One to Square Two
Survival analysis Brian Healy, PhD. Previous classes Regression Regression –Linear regression –Multiple regression –Logistic regression.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 10: Survival Curves Marshall University Genomics Core.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
HSRP 734: Advanced Statistical Methods July 10, 2008.
Lecture 3 Survival analysis.
1 Introduction to medical survival analysis John Pearson Biostatistics consultant University of Otago Canterbury 7 October 2008.
INTRODUCTION TO SURVIVAL ANALYSIS
Chapter 12 Survival Analysis.
Generalized pairwise comparisons of prioritized outcomes Marc Buyse, ScD
Censoring an observation of a survival r.v. is censored if we don’t know the survival time exactly. usually there are 3 possible reasons for censoring.
BPS - 5th Ed. Chapter 221 Two Categorical Variables: The Chi-Square Test.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
Satistics 2621 Statistics 262: Intermediate Biostatistics Jonathan Taylor and Kristin Cobb April 20, 2004: Introduction to Survival Analysis.
01/20151 EPI 5344: Survival Analysis in Epidemiology Quick Review from Session #1 March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health &
Topic 19: Survival Analysis T = Time until an event occurs. Events are, e.g., death, disease recurrence or relapse, infection, pregnancy.
02/20161 EPI 5344: Survival Analysis in Epidemiology Hazard March 8, 2016 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
SURVIVAL ANALYSIS PRESENTED BY: DR SANJAYA KUMAR SAHOO PGT,AIIH&PH,KOLKATA.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
Carolinas Medical Center, Charlotte, NC Website:
HOW TO BIAS A KAPLAN-MEIER CURVE
An introduction to Survival analysis and Applications to Predicting Recidivism Rebecca S. Frazier, PhD JBS International.
Comparison of Two Survival Curves
Martha A. Wojtowycz, PhD February 26, 2016
April 18 Intro to survival analysis Le 11.1 – 11.2
Quality of Life Assessment
Impact of censoring on the statistical methods for handling non-proportional hazards in Immuno-Oncology studies Yifan Huang, Luping Zhao, Jiabu Ye, and.
Survival Analysis: From Square One to Square Two Yin Bun Cheung, Ph.D. Paul Yip, Ph.D. Readings.
Copyright © 2000 American Medical Association. All rights reserved.
Copyright © 2014 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
Clinical outcome after SVR: Veterans Affairs
From: Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 YearsA Comparative Modeling Study of Risk Ann Intern.
Statistical Inference for more than two groups
Probability Distributions for Discrete Variables
Statistics 103 Monday, July 10, 2017.
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Sample Size Planning of Clinical Trials, Introduction
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Heart failure.
Chapter 4 SURVIVAL AND LIFE TABLES
Non-parametric methods in statistical testing
Where are we?.
(A) Mortality in patients with heart failure and different estimated glomerular filtration rate (eGFR) strata, crude survival assessed by Kaplan-Meier.
Perioperative associates of exaggerated heart rate responses pre-exercise. Perioperative associates of exaggerated heart rate responses pre-exercise. (A)
Stavros V. Konstantinides et al. JACC 2017;69:
Kaplan-Meier survival estimates for major cardiovascular events.
Kaplan-Meier curves for overall survival in patients with adenocarcinoma and time since first-line therapy of
Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier plots. Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier.
Kaplan-Meier survival curves and the log rank test
Presentation transcript:

Survival Analysis Rick Chappell, Ph.D. Professor, Department of Biostatistics and Medical Informatics University of Wisconsin School of Medicine & Public Health chappell@stat.wisc.edu BMI 542 – Week 6, Lecture 1 (slides adapted in part from D. DeMets’) 2

Survival Analysis Terminology Concerned about time to some event Event is often death Event may also be, for example 1. Cause-specific death 2. Recurrence of tumor or death, whichever comes first 3. Death or some non-fatal event 4. Release from hospital; marriage; divorce; job tenure; job acquisition …

Survival Rates at Yearly Intervals YEARS At 5 years, survival rates the same Survival experience in Group A appears more favorable, considering 1 year, 2 year, 3 year and 4 year rates together

Beta-Blocker Heart Attack Trial LIFE-TABLE CUMULATIVE MORTALITY CURVE

Survival Analysis 1. Estimation of survival curves 2. Comparison of survival curves Estimation Simple Case All patients entered at the same “time” and followed for the same length of time Survival curve is estimated at various time points by (number of deaths)/(number of patients) As intervals become smaller and number of patients larger, a smoother survival curve may be plotted Typical Clinical Trial Setting

Staggered Entry T years 1 T years 2 Subject T years 3 T years 4 T 2T Time Since Start of Trial (T years) Each patient has T years of follow-up Time for follow-up taking place may be different for each patient

• * * Subject o Administrative 1 Right Censoring 2 Failure 3 Loss to Follow-up * 4 Failure T 2T Time Since Start of Trial (T years) Failure time is time from entry until the time of the event Right Censoring means vital status of patient is not known beyond that point

* • * Subject Administrative Censoring 1 o 2 Failure 3 Censoring Loss to Follow-up 4 * Failure T Follow-up Time (T years)

Clinical Trial with Common Termination Date Subject 1 o 2 * 3 • 4 • o 5 • * • • 6 7 • • 8 • * 9 • o o 10 • o * 11 • o o T 2T Follow-up Time (T years) Trial Terminated

Kaplan-Meier Estimate (JASA, 1958) – see “KM.mechanics” pdf Assumptions 1. "Exact" time of event is known Failure = uncensored event Loss = censored event Failures are independent of Losses! See KMBias.ppt 2. For a "tie", failure always before loss (minor) 3. Divide follow-up time into intervals such that a. Each event defines left side of an interval b. No interval has both deaths & losses

2. Comparison of Two Survival Curves Assume that we now have a treatment group and a control group and we wish to make a comparison between their survival experience How do we do so in a way which builds upon the Kaplan-Meier estimator? Point-wise at a “landmark” time using Greenwood. Medians? Mantel-Haenszel (log rank) test, with equal weighting; Peto-Prentice (Gehan) test, with earlier events upweighted & later ones downweighted.